CAS 91300-60-6
:6-(Phenylamino)-5,8-quinolinedione
- 5,8-Dihydro-5,8-dioxo-6-(phenylamino)quinoline
- 5,8-Quinolinedione, 6-(phenylamino)-
- 6-(Phenylamino)-5,8-quinolinedione
- 6-Anilinoquinoline-5,8-quinone
- Comr 2029
- Ly 83583
- Ly83583
LY83583
CAS:LY83583 is a soluble guanylate cyclase competitive inhibitor with IC50 of 2 µM.
Formula:C15H10N2O2Purity:99.54% - 99.80%Color and Shape:SolidMolecular weight:250.256-(Phenylamino)quinoline-5,8-dione
CAS:6-(Phenylamino)quinoline-5,8-dionePurity:≥95%Color and Shape:Red-Brown SolidMolecular weight:250.25g/mol6-Anilino-5,8-quinolinedione
CAS:Controlled ProductApplications Inhibits nitric-oxide-induced activation of soluble guanylate cyclase (IC50=2µM) in a dose-dependent and reversible manner. It blocks acetylcholine induced vasorelaxation. Also an inhibitor of antigen-induced leukotriene release.
References Macleod, K.M., et al.: Mol. Pharmacol., 32, 59 (1987), Mulsch, A. J.: J. Pharmacol. Exp. Ther., 247, 283 (1988), Mulsch, A., et al.: Naunyn-Schmiedeberg's Arch. Pharmacol., 340, 119 (1989), Light, D.B., et al.: Science, 243, 383 (1989), Beasley, D., et al.: J. Clin. Invest., 87, 602 (1991)Formula:C15H10N2O2Color and Shape:NeatMolecular weight:250.256-Anilinoquinoline-5,8-quinone
CAS:6-Anilinoquinoline-5,8-quinone is a chemical compound that belongs to the family of cyclase inhibitors. It has been shown to inhibit cyclase and cytosolic Ca2+, which are intracellular targets for HIV infection. 6-Anilinoquinoline-5,8-quinone inhibits the transcription of HIV by binding to dinucleotide phosphate in the cell nucleus. This compound has also been shown to have anti-inflammatory properties through its ability to inhibit prostaglandin synthesis and reduce the production of inflammatory cytokines. 6-Anilinoquinoline-5,8-quinone has been shown to be pluripotent in vitro and can induce a number of physiological effects in cells such as increased protein synthesis and reduced cellular respiration.
Formula:C15H10N2O2Purity:Min. 95%Molecular weight:250.25 g/mol





